Found 67 matching trials
Study of Regorafenib After Sorafenib in Patients With Hepatocellular Carcinoma PHASE3 The objective of this study was to evaluate efficacy and safety of regorafe...
Show More Location
Multiple Locations
Learn More & Join Trial
Phase IIb Study of AST-3424 in Patients With AKR1C3-high Expressing Advanced Hepatocellular Carcinoma PHASE2 The goal of this clinical trial is to learn if drug AST-3424 works to treat...
Show More Location
Nanjing Tianyinshan Hospital
Learn More & Join Trial
A Study of Regorafenib Combined With Envafolimab for Metastatic Gastrointestinal Stromal Tumors With Kit Gene Exon 17 Mutation That Failed Standard Treatment PHASE2 This study is a multicenter, prospective, randomized controlled Phase II cl...
Show More Location
Beijing Cancer Hospital, 52 Fucheng Road
Learn More & Join Trial
Continuous Dosing of BAY73-4506 in Patients With Advanced Malignancies PHASE1 Continuous dosing of BAY73-4506 in patients with advanced cancer...
Location
Multiple Locations
Learn More & Join Trial
Assessment of Physical Activity During Therapy With Regorafenib for Metastatic Colorectal Cancer N/A The purpose of this trial is to quantitatively assess the average amount of...
Show More Location
Klinikum Kreuzschwestern Wels GmbH
Learn More & Join Trial
Phase II Study of Regorafenib as Maintenance Therapy PHASE2 Multicenter double-blind placebo-controlled randomized Phase II study compa...
Show More Learn More & Join Trial
Regorafenib for Recurrent Meningioma (MIRAGE Trial) PHASE2 The focus of this study will be to investigate whether Regorafenib demonstr...
Show More Location
IRST Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori"
Learn More & Join Trial
Regorafenib in Patients With Metastatic Solid Tumors Who Have Progressed After Standard Therapy PHASE2 This is a single arm, single-stage, phase II trial to evaluate the activity...
Show More Location
Istituto Clinico Humanitas
Learn More & Join Trial
Study of Ruxolitinib in Colorectal Cancer Patients PHASE2 The purpose of this study was to determine if ruxolitinib, in combination w...
Show More Location
Multiple Locations
Learn More & Join Trial
First Line Treatment of Metastatic Colorectal Cancer With mFOLFOX6 in Combination With Regorafenib PHASE2 This is a study to evaluate the efficacy (effectiveness) and the safety of ...
Show More Location
Multiple Locations
Learn More & Join Trial